Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach-Reference-Cited by-同舟云学术

Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach

Published:2018-04 Issue:4 Volume:7 Page:305-317
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Shammas Nicolas W¹,Boyes Christopher W²,Palli Swetha R³,Rizzo John A⁴,Martinsen Brad J⁵,Kotlarz Harry⁶,Mustapha JA⁷

Affiliation:

1. Midwest Cardiovascular Research Foundation, Davenport, IA 52803, USA

2. Vascular Surgery, Sanger Heart & Vascular Institute at Carolinas Medical Center, Charlotte, NC 28203, USA

3. Health Outcomes Research, CTI Clinical Trials & Consulting Services Inc., Covington, KY 41011, USA

4. Department of Family, Population & Preventive Medicine & Department of Economics, Stony Brook University, Stony Brook, NY 11790, USA

5. Scientific Affairs, Cardiovascular Systems Inc., St Paul, MN 55112, USA

6. Health Economics & Reimbursement, Cardiovascular Systems Inc., St Paul, MN 55112, USA

7. Cardiovascular Research, Metro Health University of Michigan Health Wyoming, MI 49519, USA

Abstract

Aim: The incremental cost of peripheral orbital atherectomy system (OAS) plus balloon angioplasty (BA) versus BA-only for critical limb ischemia was estimated. Materials & methods: A deterministic simulation model used clinical and healthcare utilization data from the CALCIUM 360° trial and current cost data. Incremental cost of OAS + BA versus BA-only included differential utilization during the procedure and adverse-event costs at 3, 6 and 12-months. Results: For every 100 procedures, incremental annual costs to the hospital were US$350,930 lower with OAS + BA compared with BA-only. Despite higher upfront costs, savings were realized due to reduced need for revascularization, amputation and end-of-life care over 6–12-month postoperative period. Conclusion: Atherectomy with OAS prior to BA was associated with cost savings to the hospital.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2017-0070

Reference49 articles.

1. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia

2. Variation in the Use of Lower Extremity Vascular Procedures for Critical Limb Ischemia

3. ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Below-the-Knee Endovascular Revascularization;JACC: Cardiovascular Interventions;2024-03

2. A Systematic Review and Meta-analysis of Atherectomy Plus Balloon Angioplasty Versus Balloon Angioplasty Alone for Infrapopliteal Arterial Disease;Journal of Endovascular Therapy;2023-11-07

3. Atherectomy Before Angioplasty or Stenting for Peripheral Arterial Disease: Point—The Data Indicate That Atherectomy Before Definitive Endovascular Therapy Is Beneficial;American Journal of Roentgenology;2023-05

4. Factors in Sufficient Endovascular Vessel Preparation for Severely Calcified Femoropopliteal Lesions;Circulation Journal;2023-02-24

5. Limitations in the Analysis of Atherectomy Using Medicare Big Data;Journal of Endovascular Therapy;2020-09-04